|Table of Contents|

Progress in the identification of clonal origin and treatment of multifocal hepatocellular carcinoma

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

2017 10
Research Field:
Publishing date:


Progress in the identification of clonal origin and treatment of multifocal hepatocellular carcinoma
Fan Yongguo1Zhou Feng1Zhai Yulong1Shi Wencong1Dang Ling1Du Xiaohong2He Xianli1
1.Department of General Surgery,Tangdu Hospital,The Fourth Military Medical University,Shaanxi Xi'an 710038,China,2.Teaching and Experiment Center,The Fourth Military Medical University,Shaanxi Xi'an 710032,China.
hepatocellular carcinomamulticentric origin (MO)intrahepatic metastasis (IM)
Hepatocellular carcinoma (HCC) is one of the most common malignancies in the world.It has the characteristics of occult onset and rapid development.Most of the patients have been diagnosed too late.In addition,about half of primary liver cancer patients,especially hepatocellular carcinoma,showed multiple nodular lesions.The patients could be devided into intrahepatic metastasis (IM) or multicentric origin (MO),according to different origins.The treatment and prognosis of these two groups are significantly different.Therefore,the identification of the origin of multi-nodular liver cancer play very important role in improving the quality of life of patients.This article mainly reviews the relevant papers about classification and differential diagnosis of multifocal occurrence and summarizes their potential clinical value in treatment.


[1]Torre LA,Bray F,Siegel RL,et al.Global cancer statistics,2012[J].CA:A Cancer Journal for Clinicians,2015,65(2):87-108.
[2]Wei KR,Peng XB,Liang ZH,et al.Liver cancer epidemiology worldwide[J].China cancer,2015,24(8):621-630.[魏矿荣,彭侠彪,梁智恒,等.全球肝癌流行概况[J].中国肿瘤,2015,24(8):621-630.]
[3]Chen W,Zheng R,Baade PD,et al.Cancer statistics in China,2015[J].CA:A Cancer Journal for Clinicians,2016,66(2):115-132.
[4]Forner A,Llovet JM,Bruix J.Hepatocellular carcinoma[J].The Lancet,2012,379(9822):1245-1255.
[5]Matsumoto Y,Fujii H,Matsuda M,et al.Multicentric occurrence of hepatocellular carcinoma:diagnosis and clinical significance[J].J Hepatobiliary Pancreat Surg,2001,8(5):435-440.
[6]Feo F,Pascale RM.Multifocal hepatocellular carcinoma:intrahepatic metastasis or multicentric carcinogenesis[J]?Ann Transl Med,2015,3(1):4.
[7]Ishikawa T.Treatment strategy for recurrent multiple hepatocellular carcinoma[J].Journal of Cancer Therapy,2013,4(02):408-412.
[8]Shimada M,Hamatsu T,Yamashita Y,et al.Characteristics of multicentric hepatocellular carcinomas:Comparison with intrahepatic metastasis[J].World Journal of Surgery,2001,25(8):991-995.
[9]Miao R,Luo H,Zhou H,et al.Identification of prognostic biomarkers in hepatitis B virus-related hepatocellular carcinoma and stratification by integrative multi-omics analysis[J].J Hepatol,2014,61(4):840-849.
[10]Wang B,Xia C,Lau W,et al.Determination of clonal origin of recurrent hepatocellular carcinoma for personalized therapy and outcomes evaluation:A new strategy for hepatic surgery[J].Journal of the American College of Surgeons,2013,217(6):1054-1062.
[11]Morimoto O,Nagano H,Sakon M,et al.Diagnosis of intrahepatic metastasis and multicentric carcinogenesis by microsatellite loss of heterozygosity in patients with multiple and recurrent hepatocellular carcinomas[J].Journal of Hepatology,2003,39(2):215-221.
[12]Wang J,Li Q,Sun Y,et al.Clinicopathologic features between multicentric occurence and intrahepatic metastasis of multiple hepatocellular carcinomas related to HBV[J].Surgical Oncology,2009,18(1):25-30.
[13]Kubo S,Nishiguchi S,Hirohashi K,et al.Clinicopathological criteria for multicentricity of hepatocellular carcinoma and risk factors for such carcinogenesis[J].Japanese Journal of Cancer Research Gann,1998,89(4):419-426.
[14]Utsunomiya I.Pathological study on multicentric occurrence of hepatocellular carcinoma[J].Kurume Medical Journal,2005,52(4):133-138.
[15]Poon RT,Fan S,Ng IO,et al.Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma[J].Cancer,2000,89(3):500-507.
[16]Amaddeo G,Cao Q,Ladeiro Y,et al.Integration of tumour and viral genomic characterisations in HBV-related hepatocellular carcinomas[J].Gut,2015,64(5):820-829.
[17]Bréchot C.Pathogenesis of hepatitis B virus-related hepatocellular carcinoma:Old and new paradigms[J].Gastroenterology,2004,127(5):S56-S61.
[18]Bonilla Guerrero R,Roberts LR.The role of hepatitis B virus integrations in the pathogenesis of human hepatocellular carcinoma[J].Journal of Hepatology,2005,42(5):760-777.
[19]Arzumanyan A,Reis HMGP,Feitelson MA.Pathogenic mechanisms in HBV-and HCV-associated hepatocellular carcinoma[J].Nature Reviews Cancer,2013,13(2):123-135.
[20]Sung W,Zheng H,Li S,et al.Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma[J].Nature Genetics,2012,44(7):765-769.
[21]Esumi M,Aritaka T,Arii M,et al.Clonal origin of human hepatoma determined by integration of hepatitis B virus DNA[J].Cancer Research,1986,46(11):5767-5771.
[22]Yamamoto T,Kajino K,Kudo M,et al.Determination of the clonal origin of multiple human hepatocellular carcinomas by cloning and polymerase chain reaction of the integrated hepatitis B virus DNA[J].Hepatology,1999,29(5):1446-1452.
[23]Tamori A,Nishiguchi S,Nishikawa M,et al.Correlation between clinical characteristics and mitochondrial D-loop DNA mutations in hepatocellular carcinoma[J].Journal of Gastroenterology,2004,39(11):1063-1068.
[24]Fliss MS,Usadel H,Caballero OL,et al.Facile detection of mitochondrial DNA mutations in tumors and bodily fluids[J].Science,2000,287(5460):2017-2019.
[25]Nomoto S,Yamashita K,Koshikawa K,et al.Mitochondrial D-loop mutations as clonal markers in multicentric hepatocellular carcinoma and plasma[J].Clin Cancer Res,2002,8(2):481-487.
[26]Su Q,Liu Q,Wang SF,et al.Clonal analysis technology and application based on X chromosome gene polymorphism[J].Chin J Pathol,2002,31(02):66-68.[苏勤,刘茜,王淑芳,等.基于X染色体基因多态性的克隆性分析技术及其应用[J].中华病理学杂志,2002,31(02):66-68.]
[27]Gong L,Li Y,Su Q,et al.Use of X-chromosome inactivation pattern and laser microdissection to determine the clonal origin of focal nodular hyperplasia of the liver[J].Pathology,2009,41(4):348-355.
[28]Hodges KB,Cummings OW,Saxena R,et al.Clonal origin of multifocal hepatocellular carcinoma[J].Cancer,2010,116(17):4078-4085.
[29]El-Din HG,Ghafar NA,Saad NE,et al.Relationship between codon 249 mutation in exon 7 of p53 gene and diagnosis of hepatocellular carcinoma[J].Archives of Medical Science Ams,2010,6(3):348-355.
[30]He B,Tang ZY,Liu KD,et al.Analysis of the cellular origin of hepatocellular carcinoma by p53 genotype[J].Journal of Cancer Research & Clinical Oncology,1996,122(12):763-766.
[31]Xue R,Li R,Guo H,et al.Variable intra-tumor genomic heterogeneity of multiple lesions in patients with hepatocellular carcinoma[J].Gastroenterology,2016,150(4):998-1008.
[32]Tang J,Feng Y,Guo T,et al.Circulating tumor DNA in hepatocellular carcinoma:trends and challenges[J].Cell & Bioscience,2016,6(1):1-9.
[33]Nel I,David P,Gerken GG,et al.Role of circulating tumor cells and cancer stem cells in hepatocellular carcinoma[J].Hepatology International,2014,8(3):321-329.
[34]Cai S,Cheng X,Pan X,et al.Emerging role of exosomes in liver physiology and pathology[J].Hepatol Res,2016,18:12794.
[35]Konstantinidis IT,Fong Y.Hepatocellular carcinoma in the modern era:transplantation,ablation,open surgery or minimally invasive surgery?-A multidisciplinary personalized decision[J].Chin J Gen Surg,2015,24(7):920-927.[Konstantinidis IT,Fong Y.肝癌在当今时代:移植、消融、开放手术或微创手术?-多学科的个性化决定[J].中国普通外科杂志,2015,24(7):920-927.]
[36]Matsuda M,Fujii H,Kono H,et al.Surgical treatment of recurrent hepatocellular carcinoma based on the mode of recurrence:repeat hepatic resection or ablation are good choices for patients with recurrent multicentric cancer[J].J Hepatobiliary Pancreat Surg,2001,8(4):353-359.
[37]Jiang L,Yan L,Wen T,et al.Comparison of outcomes of hepatic resection and radiofrequency ablation for hepatocellular carcinoma patients with multifocal tumors meeting the barcelona-clinic liver cancer stage a classification[J].Journal of the American College of Surgeons,2015,221(5):951-961.
[38]Yin L,Li H,Li A,et al.Partial hepatectomy vs.transcatheter arterial chemoembolization for resectable multiple hepatocellular carcinoma beyond Milan criteria:A RCT[J].Journal of Hepatology,2014,61(1):82-88.
[39]Huang Z,Liang B,Xiong M,et al.Long-term outcomes of repeat hepatic resection in patients with recurrent hepatocellular carcinoma and analysis of recurrent types and their prognosis:A single-center experience in china[J].Annals of Surgical Oncology,2012,19(8):2515-2525.
[40]Li S,Su M,Peng T,et al.Clinicopathologic characteristics and prognoses for multicentric occurrence and intrahepatic metastasis in synchronous multinodular hepatocellular carcinoma patients[J].Asian Pacific Journal of Cancer Prevention,2013,14(1):217-223.
[41]Arii S,Monden K,Niwano M,et al.Results of surgical treatment for recurrent hepatocellular carcinoma; comparison of outcome among patients with multicentric carcinogenesis,intrahepatic metastasis,and extrahepatic recurrence[J].J Hepatobiliary Pancreat Surg,1998,5(1):86-92.


Last Update: 2017-04-01